1236189-40-4

Basic information

• Product Name: 3-fluoro-N'-hydroxy-4-(hydroxymethyl)benzimidamide
• CAS NO: 1236189-40-4
• Molecular Weight: 184.17
• Mol File: 1236189-40-4.mol

Chemical Properties

• CAS DataBase Reference: 3-fluoro-N'-hydroxy-4-(hydroxymethyl)benzimidamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-fluoro-N'-hydroxy-4-(hydroxymethyl)benzimidamide(1236189-40-4)
• EPA Substance Registry System: 3-fluoro-N'-hydroxy-4-(hydroxymethyl)benzimidamide(1236189-40-4)

Safety Data

• Hazardous Substances Data: 1236189-40-4(Hazardous Substances Data)

Upstream product

• 219873-06-0 3-fluoro-4-(hydroxymethyl)benzonitrile 

Downstream Products

• 1260437-04-4 C₉H₇FN₂O₂ 
• 1236189-41-5 (2-fluoro-4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)phenyl)methanol 

Relevant articles and documents

A synthesis of the γ-secretase inhibitor BMS-708163

A concise, convergent racemic synthesis of BMS-708163 is reported. Two fragments consisting of N-4chlorophenylsulfonyl-3,3,3-trifluorpropylglycine and a 1,2,4-oxadiazole derivative of 2-fluorobenzyl alcohol were prepared in separate pots and then coupled

SUBSTITUTED OXADIAZOLE DERIVATIVES AS S1P AGONISTS IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES

Disclosed are compounds of Formula (I) [INSERT CHEMICAL STRUCTURE HERE] (I) or pharmaceutically acceptable salts thereof, wherein Q is [INSERT CHEMICAL STRUCTURE HERE] or [INSERT CHEMICAL STRUCTURE HERE]; R1 is alkyl or aryl, said aryl optionally substituted with one to five substituents independently selected from C1 to C6 alkyl, C1 to C4 haloalkyl, OR4, and/or halogen; and R2, R3, R4, and n are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.